San Mateo, CA (PRWEB) August 31, 2012
Entelos, a premier provider of in silico modeling and simulation products and consulting services worldwide, has expanded its sales and leadership teams with three key hires: Greg Lee, Lori Waldron, and Chris Macri.
I am delighted to welcome Greg Lee, Lori Waldron and Chris Macri to the Entelos team. They are joining Entelos at an exciting time and bring the experienced talent we need to drive our business growth, said Shawn OConnor, president and CEO of Entelos. More than ever, we are focused on expanding our business and elevating our brand. To achieve this goal we will be broadening our line of software product offerings while we continue to support and expand our customer base. These new members will help move our sales and development efforts forward and provide further support to drive business growth.
Greg Lee has taken on the position of VP of Software Development. Dr. Lee has more than 30 years of experience in software development for organizations providing scientific and technical products in computer graphics, high-speed computing, finance, semiconductors, and drug development. Immediately prior to joining Entelos, Dr. Lee was a member of the technical staff at Voleon Capital Management, a statistical arbitrage fund. From 1995 to 2009 he was Vice President and co-founder at Pharsight Corporation, a provider of software and strategic consulting services to the pharmaceutical industry.
Lori Waldron has joined Entelos as Director of Business Development. Lori has sales and sales management experience that spans a career of 23 years. She has a solid track record of representing innovative products and services with proven success in start-up, fast growth, and mature organizations. Before joining Entelos, Lori was a Director of North American Sales with Oracle focused on clinical operations and drug safety software applications.
Chris Macri, has also joined Entelos as Director of Business Development. Chris comes to Entelos directly from NAFTA for BASF/Metanomics Health where he served as Senior Business Development Manager. He has also worked for Metabalon, Ingenuity systems, Accelrys and Bio-Rad all various business management roles in life sciences tools and services organizations that honed his experience in computational biology and metabolomics as well as customer service and sales.
Entelos is an in silico modeling and simulation software and services company delivering advanced predictive technologies reducing the risk, time, and cost of product development for pharmaceutical, biotechnology, nutrition and consumer products customers. The Company’s PhysioLab systems biology platforms generate virtual patient populations providing highly predictive analyses to assist customers develop safer and more effective drugs, foods and consumer products. Entelos understanding of the drivers of patient variability has significant application to the emerging field of personalized medicine. The Company is headquartered in San Mateo, California. For more information, please visit http://www.entelos.com.